Last updated on January 2020

Pneumococcal Vaccination to Accelerate Immune Recovery in Sepsis Survivors


Brief description of study

The VACIRiSS trial is a phase-IV, multi-centre placebo controlled randomised trial of conjugate pneumococcal vaccine in adult sepsis survivors.

Detailed Study Description

The aim of VACIRiSS trial is to evaluate the immunogenicity and heterologous effects of single dose 13-valent conjugate pneumococcal vaccine (PCV-13) in preventing infection related rehospitalisation in sepsis survivors and to collect outcome event data with necessary precision to inform future definitive trial design.

Clinical Study Identifier: NCT03565159

Find a site near you

Start Over